Shanghai Shen Lian Bio-Medicine Co., Ltd. (688098)
SSE SSE Primary Summary
688098 Chart
People also search for
Shanghai Shen Lian Bio-Medicine Co., Ltd. (688098) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Shanghai Shen Lian Bio-Medicine Co., Ltd. ever had a stock split?
Shanghai Shen Lian Bio-Medicine Co., Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Dongsheng Nie CEO | SSE Exchange | CNE100003P17 ISIN |
| CN Country | 380 Employees | 13 Jun 2023 Last Dividend | - Last Split | - IPO Date |
Overview
Shanghai Shen Lian Biomedical Corporation, established in 2001 and based in Shanghai, China, operates within the biotechnological sector, focusing primarily on the veterinary field. The company is dedicated to the research, development, manufacture, and distribution of veterinary biological products across China. With its innovative approach, Shanghai Shen Lian Biomedical Corporation specializes in advancing veterinary healthcare, specifically targeting the prevention and treatment of significant animal diseases through the development of synthetic peptide vaccines.
Products and Services
- Synthetic Peptide Vaccines: The cornerstone of Shanghai Shen Lian Biomedical Corporation's product lineup, synthetic peptide vaccines are designed to combat foot-and-mouth disease among livestock. Developed through extensive research and utilizing advanced biotechnology, these vaccines aim to provide a highly effective and safer option for preventing this highly contagious viral disease, which affects cloven-hoofed animals. Their approach focuses on minimizing outbreaks, thereby supporting the agricultural sector and ensuring food security.
